相关实验视频

Updated: May 11, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.5K

在与神经保护相关的临床前模型中探索有希望的自然小化合物

Carlos Franciney Moreira Vasconcelos1, Agnieszka Zofia Neugebauer2, Ricardo Basto Souza3

  • 1University of Medicine of Göttingen (UMG), Göttingen, Germany.

Basic & clinical pharmacology & toxicology
|April 3, 2024
PubMed
概括

化合物在保护大脑细胞免受损伤方面表现有前途. 这篇评论探讨了最近关于它们对抗神经退行性疾病 (如阿尔茨海默氏症和帕金森症) 的潜力的发现.

关键词:
尤金诺醇是一种复星醇是一种神经保护神经保护聚醇是一种多醇.二次代谢产物二次代谢产物

更多相关视频

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats10:15

A Preclinical Model to Assess Brain Recovery After Acute Stroke in Rats

Published on: November 6, 2019

8.3K
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.5K

相关概念视频

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).